Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John Burd
AddedMar 31, 2024
UpdatedJun 28, 2026
John Burd

John Burd

Founder, Dexcom

Crunchbase

John Burd's Career

Dexcom
Dexcom

San Diego, CA, US

Founder
Oculir
Oculir

San Diego, CA, US

Founder
Freedom Meditech
Freedom Meditech

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John Burd's Career

Dexcom
Dexcom

San Diego, CA, US

Founder
Oculir
Oculir
Series A$7.3M52003San Diego, CA, US
Founder

Similar to Oculir

OcuSciencesOcuSciencesAnn Arbor, MI, USMedical Devicesest. 2008OcuSciencesAnn Arbor, MI, US · est. 2008

OcuSciences: Innovating non-invasive ocular imaging devices for early detection and treatment of diabetes-related eye conditions.

Seed · $900k7
GlucoVistaGlucoVistaFairfield Township, NJ, USMedical Devicesest. 2006GlucoVistaFairfield Township, NJ, US · est. 2006

GlucoVista Inc.: A US-based medical device company specializing in non-invasive blood glucose measuring equipment.

Seed · $2.7M3
Newton PhotonicsNewton PhotonicsNewton, MA, USGlucose Monitorsest. 2001Newton PhotonicsNewton, MA, US · est. 2001

Newton Photonics develops non-invasive, optical sensing glucose monitors for diabetes patients.

Angel · $149.8k5
OculogicaOculogicaNew York City, NY, USMedical Devicesest. 2013OculogicaNew York City, NY, US · est. 2013

NY-based Oculogica Inc, founded in 2013, specializes in manufacturing electro-medical apparatus.

Series B · $17.7M13
Freedom Meditech
Freedom Meditech
Series C$19.6M302006San Diego, CA, US
Board Member· Board

Leadership at Freedom Meditech

Craig MisrachCraig MisrachFounder
Keith IgnotzKeith IgnotzBoard Member
Andrew SassineAndrew SassineBoard Member
Mr. Craig H. MisrachMr. Craig H. MisrachBoard Member

Similar to Freedom Meditech

Free Flow MedicalFree Flow MedicalFremont, CA, USMedical Devicesest. 2017Free Flow MedicalFremont, CA, US · est. 2017

Free Flow Medical: Innovating next-gen devices for emphysema treatment to enhance patient life quality.

Series B · $4.9M30
Bioxytech RetinaBioxytech RetinaRichmond, CA, USMedical Devicesest. 2015Bioxytech RetinaRichmond, CA, US · est. 2015

Bioxytech Retina, founded in 2015, pioneers non-invasive optical devices for diabetes diagnosis.

Pre-Seed · $1.2M5
Channel MedsystemsChannel MedsystemsSan Francisco, CA, USMedical Devicesest. 2009Channel MedsystemsSan Francisco, CA, US · est. 2009

San Francisco-based Channel Medsystems develops and delivers non-invasive medical technology products.

Series A · $62.9M35
Noninvasive Medical TechnologiesNoninvasive Medical TechnologiesLas Vegas, NV, USMedical Devicesest. 2006Noninvasive Medical TechnologiesLas Vegas, NV, US · est. 2006

NMT: Innovating noninvasive hemodynamic monitoring tools for enhanced medical care since 2003.

Series A · $6.3M11

John Burd's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to John Burd

Kevin SayerKevin SayerBoard Member · DexcomJonathan LordJonathan LordBoard Member · DexcomDoug KanterDoug KanterCo-Founder · DatabetesJoshua WindmillerJoshua WindmillerCo-Founder · BiolinqSrinivasa NagallaSrinivasa NagallaCo-Founder · DiabetomicsJohn WilcoxJohn WilcoxCo-Founder & CEO · Diatech Diabetes